SKBSSKBSSKBS

SKBS

No trades
See on Supercharts
Market capitalization
‪4.48 T‬KRW
‪22.32 B‬KRW
‪369.51 B‬KRW
‪24.24 M‬
Beta (1Y)
1.27

About SKBS

CEO
Jae-Yong An
Headquarters
Seongnam-si
Employees (FY)
‪1.1 K‬
Founded
2008
ISIN
KR7302440003
FIGI
BBG00Z5YRKV4
SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1, 2018 and is headquartered in Seongnam-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 302440 is 57300 KRW — it has decreased by 0.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SKBS stocks are traded under the ticker 302440.
SKBS is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
302440 stock is 0.70% volatile and has beta coefficient of 1.27. Check out the list of the most volatile stocks — is SKBS there?
302440 earnings for the last quarter are 638.15 KRW per share, whereas the estimation was 927.74 KRW resulting in a −31.21% surprise. The estimated earnings for the next quarter are −119.26 KRW per share. See more details about SKBS earnings.
SKBS revenue for the last quarter amounts to ‪231.80 B‬ KRW despite the estimated figure of ‪130.85 B‬ KRW. In the next quarter revenue is expected to reach ‪62.16 B‬ KRW.
Yes, you can track SKBS financials in yearly and quarterly reports right on TradingView.
302440 stock has fallen by 0.52% compared to the previous week, the month change is a 8.90% fall, over the last year SKBS has showed a 19.64% decrease.
302440 net income for the last quarter is ‪4.17 B‬ KRW, while the quarter before that showed ‪48.39 B‬ KRW of net income which accounts for −91.38% change. Track more SKBS financial stats to get the full picture.
Today SKBS has the market capitalization of ‪4.48 T‬, it has increased by 2.63% over the last week.
No, 302440 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 302440 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SKBS stock right from TradingView charts — choose your broker and connect to your account.
302440 reached its all-time high on Aug 17, 2021 with the price of 362000 KRW, and its all-time low was 56700 KRW and was reached on Apr 17, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪1.10 K‬ employees. See our rating of the largest employees — is SKBS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SKBS technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SKBS stock shows the sell signal. See more of SKBS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SKBS future price: according to them, 302440 price has a max estimate of 89000.00 KRW and a min estimate of 35000.00 KRW. Read a more detailed SKBS forecast: see what analysts think of SKBS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SKBS EBITDA is ‪−8.76 B‬ KRW, and current EBITDA margin is −2.37%. See more stats in SKBS financial statements.